Viagra with Dapoxetine: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation - Evidence-Based Review
| Dosaggio del prodotto: 50 mg + 30 mg | |||
|---|---|---|---|
| Confezione (n.) | Per tablet | Prezzo | Acquista |
| 4 | €3.42 | €13.69 (0%) | 🛒 Aggiungi al carrello |
| 8 | €2.78 | €27.38 €22.25 (19%) | 🛒 Aggiungi al carrello |
| 16 | €2.35 | €54.76 €37.65 (31%) | 🛒 Aggiungi al carrello |
| 32 | €2.09
Migliore per tablet | €109.52 €66.74 (39%) | 🛒 Aggiungi al carrello |
Sinonimi | |||
Prodotti simili
Product Description: This monograph details a combination pharmaceutical product containing Sildenafil Citrate, a phosphodiesterase type 5 (PDE5) inhibitor, and Dapoxetine Hydrochloride, a selective serotonin reuptake inhibitor (SSRI). It is formulated for the dual management of erectile dysfunction (ED) and premature ejaculation (PE) in adult men. The product is presented as a film-coated tablet for oral administration, with the intent of addressing two of the most prevalent male sexual health concerns concurrently through distinct but complementary pharmacological pathways.
1. Introduction: What is Viagra with Dapoxetine? Its Role in Modern Medicine
In clinical practice, we often see a complex interplay of sexual dysfunctions, not isolated conditions. A patient presents with erectile dysfunction, but upon closer questioning—the kind you only get to after building rapport—you uncover a lifelong history of premature ejaculation that predates the ED, or vice versa. Treating one often unmasks or does nothing for the other, leaving the patient frustrated. That’s the clinical gap this combination aims to address. Viagra with Dapoxetine isn’t a novel single molecule; it’s a strategic co-formulation of two well-established agents: sildenafil (the active component in Viagra) for erectile dysfunction, and dapoxetine (approved specifically for PE) for premature ejaculation. Its significance lies in targeting the two most prevalent male sexual complaints with a single dosing regimen, which can improve adherence and address the multifaceted nature of sexual health. For the informed patient or the prescribing clinician, understanding this product is about understanding a pragmatic approach to a common comorbidity.
2. Key Components and Pharmacokinetics
The efficacy hinges on the specific pharmacokinetics of each component. Let’s break down the composition.
- Sildenafil Citrate: Typically dosed at 50mg or 100mg in this combination. It’s a PDE5 inhibitor with a rapid onset (median 30-60 minutes) and a half-life of about 4 hours. Its bioavailability is approximately 40%. High-fat meals can delay absorption, which is a crucial counseling point.
- Dapoxetine Hydrochloride: Dosed at 30mg or 60mg. It’s a short-acting SSRI, distinct from chronic antidepressants. Its peak plasma concentration is reached in about 1-1.5 hours, with a short half-life of ~1.5 hours. This rapid in-and-out profile is by design—to provide on-demand effect for PE while minimizing next-day SSRI accumulation. The bioavailability of dapoxetine is around 42%.
The combination tablet is designed for synchronized on-demand use. The release form is immediate for both agents, which is critical as both conditions require timing relative to sexual activity. The short half-life of dapoxetine is a key feature, reducing the risk of serotonin syndrome when used on-demand compared to daily SSRIs, though vigilance is still paramount.
3. Mechanism of Action: Scientific Substantiation
The mechanism of action is where the elegance of this combination lies. They work on entirely different physiological pathways, which is why they can be synergistic.
Sildenafil’s Role: During sexual stimulation, nitric oxide (NO) is released in the corpus cavernosum. This activates guanylate cyclase, increasing cyclic guanosine monophosphate (cGMP). cGMP is the key that relaxes smooth muscle, allowing blood to flow in and create an erection. Phosphodiesterase type 5 (PDE5) is the enzyme that breaks down cGMP. How Viagra with Dapoxetine works for ED is straightforward: sildenafil potently inhibits PDE5, preserving cGMP levels, thereby enhancing the natural erectile response. It has no effect without sexual stimulation.
Dapoxetine’s Role: Premature ejaculation is linked to hypersensitivity of the serotonergic pathways controlling the ejaculatory reflex. Dapoxetine, as a selective serotonin reuptake inhibitor, increases serotonin activity in the synaptic cleft of the central nervous system. This modulates the neurochemical cascade, increasing the sensory threshold for ejaculation and, clinically, increasing intravaginal ejaculatory latency time (IELT). It doesn’t cause numbness; it centralizes the control.
In combination, they work in parallel: one improving the vascular hardware, the other modulating the neurological software of the sexual response. The scientific research supporting each individually is robust; the combination studies focus on proving synergy and safety.
4. Indications for Use: What is Viagra with Dapoxetine Effective For?
This product is indicated for the on-demand, dual treatment of comorbid conditions in adult men.
Viagra with Dapoxetine for Erectile Dysfunction
For the management of ED of vascular, mixed, or mild psychogenic origin. It is effective in achieving and maintaining an erection sufficient for satisfactory sexual activity. It is not indicated for use in men without ED.
Viagra with Dapoxetine for Premature Ejaculation
For the treatment of premature ejaculation, defined as a persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration, and before the person wishes it, causing marked distress. It is indicated for men with lifelong or acquired PE.
The key is the confirmed presence of both conditions. Using it for isolated PE or isolated ED is not the intended use and exposes the patient to unnecessary side effects from the unneeded component.
5. Instructions for Use: Dosage and Course of Administration
This is not a daily medication. It is an on-demand therapy. Clarity here prevents misuse.
| Indication & Goal | Recommended Dosage (Sildenafil/Dapoxetine) | Timing | Administration Notes |
|---|---|---|---|
| Dual Therapy (ED & PE) | Start: 50mg/30mgTitrate: May increase to 100mg/60mg or decrease to 50mg/30mg based on efficacy/tolerance. | Approximately 1-3 hours before anticipated sexual activity. | Take with a full glass of water. A high-fat meal may delay onset. Do not take more than one dose in a 24-hour period. |
| Dose Adjustment | For older patients (>65), those with hepatic/renal impairment, or on CYP3A4 inhibitors, the 50mg/30mg dose is strongly recommended as the starting point. | As above. | A lower starting dose is crucial for safety in these populations. |
The course of administration is indefinite, as needed, but treatment efficacy should be re-evaluated periodically by a healthcare provider. It is not a “cure” but a control therapy.
6. Contraindications and Drug Interactions
The contraindications are extensive due to the dual pharmacology and are non-negotiable. This section is critical for safety.
Absolute Contraindications:
- Patients using any form of organic nitrates (e.g., nitroglycerin, isosorbide) or nitric oxide donors. The combination can cause a life-threatening drop in blood pressure.
- Patients with severe cardiovascular disorders (e.g., unstable angina, severe heart failure, recent myocardial infarction).
- Patients with severe hepatic impairment.
- Patients with a history of manic episodes or severe depression.
- Concomitant use with monoamine oxidase inhibitors (MAOIs), thioridazine, or other SSRIs/SNRIs/tricyclic antidepressants (due to serotonin syndrome risk).
- Known hypersensitivity to sildenafil, dapoxetine, or any excipient.
Major Drug Interactions:
- Potent CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir, clarithromycin): Can drastically increase levels of both drugs. Concurrent use is contraindicated or requires extreme dose reduction.
- Alpha-blockers (e.g., tamsulosin, doxazosin): Risk of symptomatic postural hypotension. Caution is advised.
- Other PDE5 inhibitors: Concurrent use is prohibited.
- Alcohol: Can increase orthostatic hypotension and dizziness and may worsen PE.
Common side effects are often additive: headache, flushing, dizziness, nausea, nasal congestion, dyspepsia, and insomnia. These are typically mild to moderate and transient. Importantly, clinicians must monitor for signs of serotonin syndrome (agitation, hallucinations, tachycardia, hyperthermia) and advise patients to discontinue and seek immediate care if symptoms occur.
7. Clinical Studies and Evidence Base
The clinical studies for the individual components are legion. Sildenafil’s ED data spans decades. Dapoxetine’s approval was based on multiple randomized, double-blind, placebo-controlled trials involving thousands of men with PE, showing a 2.5 to 3-fold increase in IELT.
The evidence for the combination comes from studies like the one by McMahon et al. (2013), which demonstrated that in men with comorbid ED and PE, sildenafil 100mg plus dapoxetine 60mg was superior to either component alone in improving both erection quality and IELT, while maintaining a manageable side effect profile. Patient-reported outcomes, like confidence and control, also showed significant improvement. The effectiveness is considered well-established for the comorbid population it targets. However, the scientific evidence also clearly shows no added benefit for men with only one condition.
8. Comparing Viagra with Dapoxetine with Similar Products and Choosing Quality
When patients ask about Viagra with Dapoxetine similar products, they’re usually asking about a few things: using separate pills, other PDE5i+SSRI combos, or compounded versions.
- Separate Pills vs. Combination: The separate pill strategy (e.g., taking Viagra and Priligy from separate blisters) offers dose flexibility but harms adherence. The fixed-dose combination improves convenience and adherence, which is a major factor in treatment success.
- Other PDE5 Inhibitors: Tadalafil (Cialis) has a longer half-life. There’s no approved tadalafil/dapoxetine combo, and using long-acting tadalafil with short-acting dapoxetine creates mismatched pharmacokinetics and potentially prolongs SSRI exposure.
- Compounded Products: Some specialty pharmacies compound similar combinations. Choosing a quality product means insisting on regulatory-approved formulations from licensed manufacturers. Compounded versions may have variable bioavailability and lack the rigorous batch testing of approved drugs. The approved product ensures consistent dose, purity, and reliable dissolution.
9. Frequently Asked Questions (FAQ) about Viagra with Dapoxetine
What is the recommended course of Viagra with Dapoxetine to achieve results?
It is an on-demand therapy. You take one tablet as needed, not daily. Consistent use over several attempts is often needed to build confidence and see optimal results, but the pharmacological effect is present with each dose.
Can Viagra with Dapoxetine be combined with antidepressants like sertraline?
No. This is a critical point. Combining dapoxetine (an SSRI) with another SSRI like sertraline, fluoxetine, or citalopram significantly increases the risk of serotonin syndrome, a potentially life-threatening condition. This combination is contraindicated.
Is a prescription required for Viagra with Dapoxetine?
Yes. It is a prescription-only medication (Schedule III in many jurisdictions) due to its potent effects, significant side effect profile, and numerous contraindications. A proper medical evaluation is mandatory.
How long do the effects last?
The window for effect is typically 4-6 hours for the erectile component (sildenafil) and slightly shorter for the ejaculatory control (dapoxetine), centered around the 1-3 hour post-dose period.
What if I don’t have sexual activity after taking it?
The medication will be metabolized and excreted. No “build-up” occurs due to the short half-lives. You may experience some side effects during that day. Do not take another dose within 24 hours.
10. Conclusion: Validity of Viagra with Dapoxetine Use in Clinical Practice
The validity of Viagra with Dapoxetine use is firmly established for its specific niche: the adult male with confirmed, comorbid erectile dysfunction and premature ejaculation. The risk-benefit profile is favorable for this population when prescribed responsibly after cardiovascular and psychiatric screening, and with thorough patient counseling on contraindications (especially nitrates and other SSRIs) and side effects. It represents a pragmatic, evidence-based tool in sexual medicine that acknowledges the complexity of real-world patient presentations. For the right patient, it can simplify treatment and significantly improve quality of life and sexual relationship satisfaction.
Personal Anecdote & Clinical Experience:
I remember when this concept first hit our uro-andrology clinic. There was a split in the team. The older, more conservative consultants were wary—“polypharmacy,” “creating a one-pill-fixes-all mentality,” “safety nightmare.” The younger fellows, myself included, saw the frustrated men shuffling between our ED clinic and the psychosexual therapists for PE. We were piecing together regimens that looked exactly like this combo, just from two separate boxes. The adherence was terrible.
The first patient I prescribed the approved combo to was Mark, a 42-year-old with hypertension controlled on an ARB (no nitrates, crucial). He had developed ED post-divorce, but in digging, his PE was lifelong. He’d tried a PDE5 inhibitor alone from an online source. “The erection was okay, doc, but I was so anxious about finishing fast it just… deflated the moment.” Classic performance anxiety feedback loop.
We started him on 50/30. He came back two months later, a different man. Not just the report of improved IELT (from ~30 seconds to 4 minutes, he said) and better erection hardness scores. It was the demeanor. “I don’t have to think about it anymore. I take the one pill, and for a few hours, I’m not worried about either problem.” That was the key insight we underestimated: the psychological burden of managing two dysfunctions. The pill wasn’t just a pharmacological tool; it was a cognitive offload switch.
But it wasn’t all smooth. We had a near-miss with another patient, David, 58, who didn’t disclose he’d just started St. John’s Wort for “low mood” with his GP. He presented with mild agitation and tachycardia. Serotonin syndrome warning bells went off. We stopped everything, managed him supportively, and he was fine. But it drilled into us—and now it’s the first thing I emphasize in counseling—“List EVERYTHING you take. Herbal, over-the-counter, everything. This medicine does not play well with others.” That’s the real-world side effect of complacency.
We also learned it’s not a first-line for mild, situational PE with mild ED. For a guy like young Alex, 28, with mainly anxiety-driven issues, starting with dapoxetine alone and behavioral therapy was better. Throwing in the sildenafil was overkill and gave him punishing headaches. So we refined our criteria: significant organic component to the ED, or severe lifelong PE with acquired ED. It’s a scalpel, not a hammer.
The longitudinal follow-up has been revealing. Some patients, after a year or so of successful use, find they can step down—sometimes to just the PDE5 inhibitor, having broken the anxiety cycle. Others stay on it long-term. Their testimonials aren’t about superhuman performance; they’re about normalcy. “It just lets me be present,” one told me. That, in the end, is what good sexual medicine aims for: removing the obstacle so the person can reconnect.
The team disagreement faded as the data and our own experience piled up. Now, it’s a standard, if carefully guarded, option in our arsenal. The development struggle was less about the science and more about changing our own clinical mindset—from treating discrete diseases to treating the whole sexual response in a real, flawed, and wonderfully complex human being.
More info:
Popular Products
Abhigra
Let me tell you about Abhigra. It’s not just another turmeric supplement that came across my desk. I first encountered it about three years ago when a particularly stubborn patient, a 62-year-old retired carpenter named Robert with osteoarthritis in both knees and low-grade metabolic syndrome, was desperate to avoid escalating his NSAID use due to borderline renal function. He’d tried everything – glucosamine, chondroitin, standard curcumin – with what he called “placebo-level relief.
Aldactone
Let’s talk about Aldactone. If you’ve been in practice for a while, you remember when it was just that weird diuretic that could cause gynecomastia and hyperkalemia, tucked away on the formulary for maybe the odd case of ascites. The journey of this drug from a niche agent to a cornerstone in heart failure and resistant hypertension is one of the more fascinating stories in pharmacotherapy, born out of both serendipity and rigorous science.
Altraz: Non-Invasive Neuromodulation for Treatment-Resistant Depression - Evidence-Based Review
Product Description: Altraz is a Class IIa medical device, specifically a non-invasive transcranial magnetic stimulation (TMS) system designed for home use under medical supervision. It employs low-intensity, patterned electromagnetic fields to modulate neural activity in the prefrontal cortex and associated limbic structures. Unlike pharmaceutical interventions, it is a neuromodulation device intended to provide a non-systemic, drug-free approach to supporting mood regulation and cognitive function in adults with Major Depressive Disorder (MDD) who have had an inadequate response to initial antidepressant therapy.
Amoxil
Prima di tutto, chiariamo subito di cosa stiamo parlando, perché nel gergo ospedaliero a volte si fa confusione. Amoxil è il nome commerciale, uno dei tanti in realtà, dell’amoxicillina. Non è un integratore, non è un dispositivo. È un antibiotico, punto. Un beta-lattamico, per la precisione, della famiglia delle aminopenicilline. La sua importanza nella pratica clinica quotidiana è tale che sarebbe difficile immaginare un reparto, uno studio medico o una farmacia di comunità senza di essa.
Androxal: Restoring Endogenous Testosterone for Hypogonadism - An Evidence-Based Review
Product Description: Androxal is the brand name for enclomiphene citrate, a selective estrogen receptor modulator (SERM) administered orally. It is distinct from its isomer, zuclomiphene, which is found in the commonly prescribed fertility drug clomiphene citrate. Androxal acts centrally at the hypothalamus to stimulate the body’s own production of testosterone and sperm, positioning it as a potential therapeutic alternative to exogenous testosterone replacement therapy (TRT) for men with specific endocrine disorders.
Apcalis SX Oral Jelly: Trattamento Rapido e Discreto per la Disfunzione Erettile - Monografia Basata sull'Evidenza
Prima di entrare nel dettaglio del documento strutturato, è fondamentale descrivere cos’è realmente questo prodotto. L’Apcalis SX Oral Jelly rappresenta un adattamento farmaceutico significativo del principio attivo Tadalafil, un inibitore della fosfodiesterasi di tipo 5 (PDE5) di seconda generazione. A differenza delle compresse tradizionali, si presenta in una formulazione gelificata orale, monodose, con diversi aromi. La sua caratteristica distintiva non è solo la via di somministrazione, ma la farmacocinetica che ne deriva: un assorbimento sublinguale e buccale più rapido, bypassando parzialmente il sistema portale epatico, il che si traduce in un inizio d’azione potenzialmente più veloce rispetto alla compressa standard.
Arimidex (Anastrozole): Effective Estrogen Suppression for Breast Cancer Therapy - Evidence-Based Review
Product Description: Arimidex is the brand name for the pharmaceutical compound anastrozole. It is classified as a non-steroidal aromatase inhibitor and is available as a prescription medication in tablet form. It is not a dietary supplement or an over-the-counter medical device. Its primary and approved use is in the field of oncology, specifically for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It functions by dramatically reducing the production of estrogen in the body, which can fuel the growth of certain types of breast cancer cells.
Aromasin
Let me start by describing what we’re really talking about here, because the name “Aromasin” gets thrown around a lot in oncology circles, but its impact is deeply personal for every patient who takes it. In essence, Aromasin is the brand name for exemestane, a steroidal aromatase inactivator. It’s not a supplement; it’s a potent, prescription-only oral medication classified as a hormonal therapy. We use it predominantly in postmenopausal women with estrogen receptor-positive (ER+) breast cancer, both in the adjuvant setting to prevent recurrence after initial treatment and in the metastatic setting to control advanced disease.
Asthalin
Let’s talk about Asthalin. In the chaos of an emergency room or the controlled anxiety of a clinic, few names carry the immediate, life-altering weight of this one. Asthalin, at its core, is salbutamol sulphate, a selective beta-2 adrenergic agonist. It’s not a new compound; its history is long and well-documented. But its role? Absolutely foundational. For the patient experiencing that terrifying constriction, the feeling of breathing through a thin straw, it is quite literally a breath of fresh air.
